论文部分内容阅读
目的:评价(药)铜165宫内节育器的有效性、副反应和可接受性,试图发现其与新型宫内节 育器使用效果的差别。方法:见本刊“我国常用口服避孕药和宫内节育器系统评估方法概述”(2005 年1期17页)。结果:与新型宫内节育器药铜γIUD、TCu220CIUD和MLCu375IUD相比,药铜165 IUD确实存在较高的脱落率和妊娠率;其续用率显著低于药铜γ和TCu220CIUD;其因症取出率高于 药铜γIUD,略低于TCu220CIUD。结论:新使用者不宜选用药铜165IUD,现用者不需取出药铜165 IUD,可继续使用。
OBJECTIVE: To evaluate the effectiveness, side effects and acceptability of (copper) I-165 IUD in an attempt to find out the difference between the efficacy and the new intrauterine device. Methods: See the publication of “China’s commonly used oral contraceptives and intrauterine device evaluation system overview” (2005 1 period 17 pages). RESULTS: Compared with the new intrauterine devices, bronchial γIUD, TCu220CIUD and MLCu375IUD, the copper IUD 165 IUD did have a higher rate of abortion and pregnancy rate. The continuum rate was significantly lower than that of bronchial γ and TCu220CIUD. Rate higher than drug bronze γIUD, slightly lower than TCu220CIUD. Conclusion: New users should not use copper 165IUD, users do not need to remove the copper 165 IUD, can continue to use.